VANADIUM(III) CHLORIDE structure 
             | 
        Common Name | VANADIUM(III) CHLORIDE | ||
|---|---|---|---|---|
| CAS Number | 7718-98-1 | Molecular Weight | 157.30000 | |
| Density | 3 | Boiling Point | N/A | |
| Molecular Formula | Cl3V | Melting Point | 250ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol | 
             
            
             
            
            GHS05, GHS07  | 
        Signal Word | Danger | |
| Name | Vanadium(III) chloride | 
|---|---|
| Synonym | More Synonyms | 
| Density | 3 | 
|---|---|
| Melting Point | 250ºC | 
| Molecular Formula | Cl3V | 
| Molecular Weight | 157.30000 | 
| Exact Mass | 155.85100 | 
| LogP | 2.06850 | 
| Storage condition | water-free area | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
  | 
                            
| Symbol | 
                                    
                                     
                                    
                                     
                                    
                                    GHS05, GHS07  | 
                            
|---|---|
| Signal Word | Danger | 
| Hazard Statements | H302-H314 | 
| Precautionary Statements | P280-P305 + P351 + P338-P310 | 
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges | 
| Hazard Codes | C:Corrosive; | 
| Risk Phrases | R22;R34 | 
| Safety Phrases | S25-S36/37/39-S45 | 
| RIDADR | UN 2475 8/PG 3 | 
| WGK Germany | 3 | 
| RTECS | YW2800000 | 
| Packaging Group | III | 
| Hazard Class | 8 | 
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| 
                                    
                                    Prevention of myelosuppression and genotoxicity induced by cisplatin in murine bone marrow cells: effect of an organovanadium compound vanadium(III)-l-cysteine.
                                    
                                    
                                     Mutagenesis 30 , 509-17, (2015) Cisplatin (CDDP) is one of the first-line anticancer drugs indicated for use against various form of human malignancies; but, the therapeutic outcome of CDDP chemotherapy is limited due to the develop...  | 
                                |
| 
                                    
                                    Syntheses and crystal structures of vanadium and iron chloride complexes with diglyme.
                                    
                                    
                                     Acta Chim. Slov. 62 , 354-61, (2015) A mononuclear molecular complex fac-[VCl3(diglyme)] (1) resulted from the reaction of VCl3 and diglyme (diglyme = di(2-methoxyethyl)ether) in dichloromethane. The violet complex 1 is a sensitive subst...  | 
                                |
| 
                                    
                                    Structure Characterization and Properties of Metal-Surfactant Complexes Dispersed in Organic Solvents.
                                    
                                    
                                     Langmuir 31 , 9006-16, (2015) This work describes the synthesis and characterization of metal-surfactant complexes. Dioctyl sulfosuccinate and dodecylbenzenesulfonate are associated with multivalent aluminum, iron, and vanadium io...  | 
                                
| EINECS 231-744-6 | 
| vanadium(iii) chloride | 
| MFCD00011454 |